Please login to the form below

Not currently logged in
Email:
Password:

open innovation

This page shows the latest open innovation news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca officially opens new R&D facility in UK

AstraZeneca officially opens new R&D facility in UK

CEO Pascal Soriot said AZ’s ambition was to “drive the next wave” of scientific innovation. ... institutions and a range of biotechs will ‘promote a culture of open partnership and innovation’.

Latest news

More from news
Approximately 16 fully matching, plus 46 partially matching documents found.

Latest Intelligence

  • We need to keep learning to keep innovating We need to keep learning to keep innovating

    Feel the fear.and do it anyway? If we continue to see innovation as a risky business that opens us up to the possibility of failure, it is almost inevitable that ... It brought together a working group of senior communicators from seven pharmaceutical

  • Creating a culture where innovation thrives Creating a culture where innovation thrives

    lives – is so compelling, we should be leading the wider communications industry in terms of creativity and innovation. ... The best campaigns are always the result of teamwork, so it’s vital that we get everyone onboard with what being open to

  • Driving the innovation engine Driving the innovation engine

    The terms are sometimes loosely defined and treated as interchangeable with open innovation. ... Open innovation imposes other challenges. People connectivity is the first step – the chance to meet, network and exchange ideas.

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    Lee is now reviewing LifeArc’s portfolio of projects, but sees scope for in-house research on pain, plus networked ‘open innovation’ style collaborative research on underserved areas such as neurology, ... So it feels like a perfect storm for the

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    Proof of that came earlier this year, when IDEA Pharm published its Pharmaceutical Innovation Index 2018. ... Jane Osbourn, AZ's site lead. The new HQ is specifically designed to foster an open, collaborative culture.

More from intelligence
Approximately 2 fully matching, plus 19 partially matching documents found.

Latest appointments

  • Ex GSK exec to lead Sanford-Burnham Ex GSK exec to lead Sanford-Burnham

    Sanford-Burnham is looking to capitalise on pharma's changing research model as companies downsize and outsource early-stage discovery and take a more open innovation approach. ... Sanford-Burnham's agile structure, no-barriers science, and partnership

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • New recommendations to stimulate braver and bolder communications

    them. The five key recommendations discussed in the report are:. Create a culture that embraces innovation. ... Healthcare communicators are invited to join the movement to open up creativity and innovation in healthcare communications:.

  • What does it mean to be an agile organisation

    The more we look outside our organisations, the more open we are to stimulus for innovation. ... It can be more difficult for innovation to come from within a traditional hierachial structure.

  • Helping Hand

    An exploration of open innovation models for the pharmaceutical industry by Strategic North. ... David Coleiro and Harry Sharman look at three crowd-sourced innovation models pharma could apply and discuss how IT giants like Apple and Google approach

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...